Six new tuberculosis (TB) vaccines are in phase one trials in Gambia, Mali, Tanzania, Ethiopia and South Africa under the supervision of World Health Organisation’s Initiative for Vaccine Research and Stop TB Programme. According to MedScape, many of the vaccines are using replicas of the bacteria. Others are recombinant vaccines where the bacteria are reproduced by genetic engineering.